Brief: Varian Truebeam Receives FDA Clearance For Low-Dose Radiotherapy For Refractory Osteoarthritis
19/03/2026 15:29
March 19 (Reuters) - Siemens Healthineers AG SHLG.DE: VARIAN TRUEBEAM RECEIVES FDA CLEARANCE FOR LOW-DOSE RADIOTHERAPY FOR ADULTS WITH MEDICALLY REFRACTORY OSTEOARTHRITIS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Siemens Healthineers AG
See all newsSiemens Healthineers forecasts slower 2027 growth as China weakness persists (updated)
Siemens Healthineers seen sliding after 'not good enough' outlook
Siemens Healthineers begins carve-out of diagnostics unit amid China weakness (updated)
Brief: Siemens Healthineers - For FY 2027, Expect Comparable Revenue Growth Between 4.0% And 5.0% Over FY 2026
Siemens Healthineers starts Diagnostics carve-out, names unit Olyrian